亚太地区全基因组和EXOME定序市场（按最终用户和国家划分）-分析和预测（2024-2033）

亚太地区全基因组和EXOME定序市场规模预计将从 2024 年的 4.259 亿美元增至 2033 年的 17.848 亿美元，2024-2033 年预测期内的复合年增长率为 15.13%。

WGS 分析整个基因组，而 WES 则专注于蛋白质转录区，其中包含大多数与疾病相关的变异。随着成本下降和应用范围扩大，这些技术正变得越来越普遍。

由于基因组学的进步、遗传患者病率的上升以及精准医疗的投资不断增加，亚太地区的全基因组和EXOME定序市场正在迅速扩张。临床诊断、个人化治疗和生物医学研究都依赖全基因组定序（WGS），它梳理一个人的 DNA，以及全EXOME定序（WES），专注于蛋白质编码区域。

由于政府的强有力倡议、生物技术产业的不断发展以及医疗保健提供者和研究机构之间日益加强的伙伴关係，中国、日本、韩国和印度等国家正在引领这一市场。由于定序技术成本的下降以及巨量资料分析和人工智慧（AI）的使用，市场正在不断扩大。

生殖医学、药物基因体学、肿瘤学和罕见疾病诊断是主要应用领域。直接面向消费者（DTC）检测服务的兴起和人们对基因检测的认识不断提高也推动了市场需求。但资料隐私、复杂法规和道德困境等问题仍然存在。

考虑到这些，由于技术进步、医疗保健成本上升以及对精准和资料驱动的医疗解决方案的需求不断增加，亚太地区的全基因组和EXOME定序市场预计将大幅增长。

本报告研究了亚太地区的全基因组和EXOME定序市场，提供了市场概况以及最终用户和特定国家的趋势以及参与市场的公司概况。

目录

执行摘要

第一章 产业展望

• 市场趋势
• COVID-19 市场影响
• 法律规范
• 供应链分析
• 市场动态概览

第二章 区域

• 区域概况
• 亚太地区

第三章 市场竞争基准化分析与公司概况

• 关键策略和发展
• 公司简介
  • BGI Group (Beijing Genomics Institute (BGI))
  • Novogene Corporation

第四章调查方法

Introduction to Asia-Pacific Whole Genome and Exome Sequencing Market

The Asia-Pacific whole genome and exome sequencing market is projected to reach $1,784.8 million by 2033 from $425.9 million in 2024, growing at a CAGR of 15.13% during the forecast period 2024-2033. WGS analyses the entire genome, whereas WES concentrates on protein-coding regions that contain the majority of disease-related variants. As costs come down and applications increase, these technologies are becoming more and more popular.

Market Introduction

The market for whole genome and exome sequencing in Asia-Pacific (APAC) is expanding quickly due to advances in genomics, an increase in the prevalence of genetic disorders, and growing investments in precision medicine. Clinical diagnostics, customised treatments, and biomedical research all depend on whole genome sequencing (WGS), which offers a thorough examination of a person's DNA, and whole exome sequencing (WES), which concentrates on protein-coding regions.

With robust government initiatives, growing biotechnology sectors, and growing partnerships between healthcare providers and research institutions, nations like China, Japan, South Korea, and India are leading this market. The market is expanding due to the declining cost of sequencing technologies, as well as the use of big data analytics and artificial intelligence (AI).

Reproductive health, pharmacogenomics, oncology, and rare disease diagnosis are important applications. Demand in the market is also being influenced by the rise of direct-to-consumer (DTC) testing services and increased awareness of genetic testing. But there are still issues like data privacy, complicated regulations, and moral dilemmas.

All things considered, the APAC whole genome and exome sequencing market is expected to grow significantly due to advancements in technology, rising healthcare costs, and the growing demand for accurate, data-driven medical solutions.

Market Segmentation:

Segmentation 1: by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Segmentation 2: by Country

• Japan
• India
• China
• Singapore
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in genome and exome sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• BGI Group
• Novogene Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Industry Outlook

• 1.1 Market Trends
  • 1.1.1 Technological Innovations in the Sequencing Technology
  • 1.1.2 Numerous Inorganic Growth Activities in the Market
• 1.2 COVID-19 Impact on Market
• 1.3 Regulatory Framework
  • 1.3.1 Legal Requirements and Framework in Japan
• 1.4 Supply Chain Analysis
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Growing Applications of Whole Genome and Exome Sequencing in Clinical Diagnostics
    • 1.5.1.2 Rising Demand for Personalized Medicine Influencing the Demand for Whole Genome and Exome Sequencing
    • 1.5.1.3 Lowering Costs and Increasing Accessibility of Genome Sequencing
    • 1.5.1.4 Ongoing Whole Genome Sequencing Government Initiatives around the World
  • 1.5.2 Market Restraints
    • 1.5.2.1 Privacy and Ethical Concerns due to Increased Risk of Security Breaches
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Increasing Usage of Sequencing Technology in Emerging Markets

2 Region

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
    • 2.2.3.1 By End User
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Australia
  • 2.2.7 Japan
  • 2.2.8 Singapore
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Key Strategies and Development
• 3.2 Company Profiles
  • 3.2.1 BGI Group (Beijing Genomics Institute (BGI))
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Novogene Corporation
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products/Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023, 2026, and 2033
• Figure 2: Key Events to Keep Track of within the Whole Genome and Exome Sequencing Market
• Figure 3: Value and Supply Chain Analysis, Whole Genome and Exome Sequencing Market
• Figure 4: Analysis of Market Navigating Factors, 2023-2033
• Figure 5: Key Clinical Applications of Whole Genome and Whole Exome Sequencing
• Figure 6: Number of Research Papers Mentioning Personalized Medicine in PubMed, 2010-2023
• Figure 7: Decreasing Genome Sequencing Costs
• Figure 8: Map of a Few Recent and Ongoing Government-Funded National Genomic-Medicine Initiatives
• Figure 9: Examples of Security Breaches in Whole Genome and Exome Sequencing
• Figure 10: China Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 11: India Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 12: Australia Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 13: Japan Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 14: Singapore Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 15: Rest-of-Asia-Pacific Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 16: Strategic Initiatives, January 2021-April 2024
• Figure 17: Share of Strategic Initiatives, January 2021-April 2024
• Figure 18: Data Triangulation
• Figure 19: Top-Down and Bottom-Up Approach
• Figure 20: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Recent Technological Innovations
• Table 4: Few Major Inorganic Growth Activities in the Whole Genome and Exome Sequencing Market
• Table 5: Whole Genome and Exome Sequencing Market (by Region), $Million, 2023-2033
• Table 6: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033